Research article · 15 Apr 2026
Conference abstractPublished 18 Aug 2016
Functional lipid mediator profiling in dissecting disease pathophysiology
Queen Mary University of London, UK
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Uncontrolled inflammation form an important component of many chronic diseases such as arthritis, asthma, periodontal disease, cardiovascular diseases and neurodegenerative diseases. Using a systems approach with self-limited sterile and infectious inflammatory exudates we mapped tissue events, cell trafficking and protein mediators and identified novel mediators from 3 families of n-3 essential fatty acid (EPA, DPA, DHA), termed resolvins, protectins and maresins. These potent mediators are coined specialized pro-resolving mediators (SPM). Complete structural elucidation and total organic synthesis of SPM demonstrated their functions in vivo in the resolution of acute inflammation in many animal models. Each SPM is structurally and functionally distinct and expedite the duration and magnitude of acute inflammatory response with actions in pico-nanogram concentration range in vivo. Using LC-MS-MS-based lipid mediator-metabololipidomics we also found that the production of these novel molecules is temporally separated from that of the classic eicosanoids in mammalian tissues. In addition, SPM were identified in a number of human tissues including lymphoid organs and milk. We also found that acute supplementation with n-3 and acetylsalicylic acid increases peripheral blood SPM levels and phagocytosis of Escherichia coli by blood leukocytes. SPM are subject to further local conversion by leukocytes, which may lead to their inactivation. We recently identified two novel maresin 1 further metabolites in the context of infection and conducted their structure elucidation. Together these findings indicate that endogenous resolution pathways may underlie prevalent diseases associated with uncontrolled inflammation and provide novel opportunities for patient stratifying using functional profiling and resolution-based pharmacology.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Romain A Colas”
- BylineArticles whose byline prints “Jesmond Dalli”

